Trial Profile
A combination of two currently approved drugs to enhance the treatment of schizophrenia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 01 Oct 2005
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 01 Oct 2005 New trial record.